SecSonar.com

Tvardi Therapeutics, Inc. (TVRD)

Tvardi Therapeutics, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Tvardi Therapeutics, Inc. (TVRD) is a Biotechnology company based in US with a market capitalization of $31.4M. Free cash flow was negative at -$23.5M. This page tracks TVRD's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 17 employees · IPO Apr 16, 2025

Valuation

Valuation & price

$4.00 · as of May 17, 2026 · -90.7% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

1.50

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$41.60$21.55$1.50Jul 25Dec 25Jul 26Jul 7, 25$21.52Jul 9, 25$22.13Jul 11, 25$27.35Jul 15, 25$26.11Jul 17, 25$23.98Jul 21, 25$25.88Jul 23, 25$28.64Jul 25, 25$26.52Jul 29, 25$25.98Jul 31, 25$25.96Aug 4, 25$26.34Aug 6, 25$24.14Aug 11, 25$24.13Aug 13, 25$23.74Aug 15, 25$24.00Aug 19, 25$24.67Aug 21, 25$26.65Aug 25, 25$29.20Aug 27, 25$30.60Aug 29, 25$29.92Sep 3, 25$28.76Sep 5, 25$31.11Sep 9, 25$31.82Sep 11, 25$35.40Sep 16, 25$33.83Sep 18, 25$38.74Sep 22, 25$37.40Sep 24, 25$37.03Sep 26, 25$36.32Sep 30, 25$38.97Oct 2, 25$37.37Oct 6, 25$40.18Oct 8, 25$39.91Oct 10, 25$41.60Oct 14, 25$7.00Oct 16, 25$6.48Oct 21, 25$5.71Oct 23, 25$5.16Oct 27, 25$4.87Oct 29, 25$4.78Oct 31, 25$4.65Nov 4, 25$4.39Nov 6, 25$3.94Nov 10, 25$4.19Nov 12, 25$4.24Nov 14, 25$4.03Nov 18, 25$4.12Nov 20, 25$3.82Nov 25, 25$3.88Nov 28, 25$4.12Dec 2, 25$3.75Dec 4, 25$4.18Dec 8, 25$4.18Dec 10, 25$4.53Dec 12, 25$4.41Dec 16, 25$4.20Dec 18, 25$3.89Dec 22, 25$3.98Dec 24, 25$4.02Dec 29, 25$4.33Jan 2, 26$4.08Jan 6, 26$3.93Jan 8, 26$4.23Jan 12, 26$4.49Jan 14, 26$4.63Jan 16, 26$4.57Jan 21, 26$4.70Jan 23, 26$4.69Jan 27, 26$4.31Jan 29, 26$3.90Feb 2, 26$3.99Feb 4, 26$3.86Feb 9, 26$3.82Feb 11, 26$3.78Feb 13, 26$3.72Feb 18, 26$3.60Feb 20, 26$3.64Feb 24, 26$3.74Feb 26, 26$4.05Mar 2, 26$3.96Mar 4, 26$4.02Mar 6, 26$3.93Mar 10, 26$3.83Mar 12, 26$3.68Mar 17, 26$3.64Mar 19, 26$3.68Mar 23, 26$3.60Mar 25, 26$3.29Mar 27, 26$3.17Mar 31, 26$3.18Apr 2, 26$3.02Apr 7, 26$2.85Apr 9, 26$2.96Apr 13, 26$3.04Apr 15, 26$3.47Apr 17, 26$3.39Apr 22, 26$3.23Apr 24, 26$3.10Apr 28, 26$3.20Apr 30, 26$3.15May 4, 26$3.54May 6, 26$3.66May 8, 26$4.18May 12, 26$3.98May 14, 26$3.96May 18, 26$4.00May 20, 26$3.85May 22, 26$3.57May 28, 26$3.49Jun 1, 26$3.22Jun 3, 26$2.95Jun 5, 26$2.89Jun 9, 26$2.78Jun 11, 26$2.71Jun 15, 26$2.67Jun 17, 26$2.58Jun 22, 26$2.68Jun 24, 26$2.35Jun 26, 26$1.50Jul 2, 26$2.02
$1.5052-week range$42.98
Loading valuation history…

Fundamentals

Key fundamentals

$31.4M

Market cap

—

Revenue growth (YoY)

88.6%

Gross margin

-$23.5M

Free cash flow (USD)

-$30.6M

Net debt

Net cash position

387.8%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2020 → 2025

FY 2020$135.1MFY 2021$23.0MFY 2022$41.9MFY 2023$21.0MFY 2024$7.1MFY 2025$0.00
$135.1M$0

Free cash flow by year

2020 → 2025

FY 2020$-5.8MFY 2021$-60.1MFY 2022$-17.9MFY 2023$-23.4MFY 2024$-62.0MFY 2025$-23.5M
-$5.8M-$23.5M

Gross margin by year

2021 → 2024

FY 202193.3%FY 202282.0%FY 202369.3%FY 202488.6%
93.3%88.6%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 8, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 11, 2026Filing
  • 8-K eventEarnings ReleaseMay 8, 2026Filing
  • Quarterly report10-Q FiledMay 8, 2026Filing
  • FinancingSecurities RegistrationMay 1, 2026Filing

Questions

Frequently asked questions

What is Tvardi Therapeutics, Inc.'s market cap?

Tvardi Therapeutics, Inc. (TVRD) has a market capitalization of $31.4M.

What is TVRD's P/E ratio?

A meaningful P/E ratio is not available for TVRD — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is TVRD's price-to-book (P/B) ratio?

TVRD trades at 1.50 times book value per share.

Are insiders buying TVRD stock?

SEC Form 4 filings show no open-market insider buys at Tvardi Therapeutics, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

IBIO

iBio, Inc.

$30.2M

OTLK

Outlook Therapeutics, Inc.

$30M

LSTA

Lisata Therapeutics, Inc.

$28.8M

IGC

IGC Pharma, Inc.

$28.7M

SABS

SAB Biotherapeutics, Inc.

$34.6M

BRNS

Barinthus Biotherapeutics plc

$27.9M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.